Blood coagulation and fibrinolysis in patients with Cushing’s syndrome: Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels - Erem, C.; Nuhoglu, I.; Yilmaz, M.; Kocak, M.; Demirel, A.; Ucuncu, O.; Ersoz, H. Onder (Journal of endocrinological investigation, 2009)
Keywords: Adult; Blood Coagulation; Carboxypeptidase B2 - blood; Cushing Syndrome - blood; Endocrinology; Female; Fibrinolysis; Humans; Lipoproteins - blood; Male; Medicine; Medicine & Public Health; Metabolic Diseases; Middle Aged; Original Articles; Plasminogen Activator Inhibitor 1 - blood; tissue factor pathway inhibitor; Cushing’s syndrome; thrombin-activatable fibrinolysis inhibitor; Hemostasis